ArticleOncoimmunology2023

Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease.

Prabha Shrestha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.